News

Stu Williamson received Fullbright-Cancer Research UK Scholar Award

18 May 2018

Huge congratulations to Stuart Williamson, from our Clinical and Experimental Pharmacology group, who received a Fulbright-Cancer Research UK Scholar Award to enable him to research at Stanford University on one of the most well-regarded and impactful scholarship programmes in the world.

Stuart was selected to continue his work on Small Cell Lung Cancer studying Vasculogenic Mimicry, a process where tumour cells generate blood vessels independent to the body’s normal process. He hopes that Stanford’s interdisciplinary approach to research will offer unique perspectives to identify novel therapeutic targets.

Commenting on receiving the Award, Stuart said: “I am incredibly excited to be awarded a Fulbright-Cancer Research UK Scholarship. This opportunity will allow me to see the unique innovative research approaches utilised at Stanford, which I hope to bring back with me to the UK. My hope is that this placement will allow me to cast a light on an extremely aggressive tumour type which will hopefully lead to new treatment approaches”.

Penny Egan CBE, Executive Director, US-UK Fulbright Commission said: “In the US-UK Fulbright Commission’s 70th year, we can look back on the lasting impact that more than 27,000 educational exchanges between Brits and Americans have had – both on participants and on our two countries. We know that this cohort of Scholars will make the most of this opportunity to immerse themselves in another culture, develop ongoing partnerships, and move us closer to fulfilling Senator Fulbright’s vision of a world of peace and prosperity through greater understanding between our peoples.”

Very well done Stu! A great achievement!!